Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

30,146 total articles

POET Technologies Shares Drop After Marvell-Owned Buyer Cancels Orders

POET Technologies Shares Drop After Marvell-Owned Buyer Cancels Orders

POET Technologies Inc. saw its stock decline sharply after it disclosed that Marvell Semiconductor, which owns Celestial AI, issued written notice on April 23, 2026 canceling all purchase orders. The canceled orders included initial production units first disclosed by POET in April 2023. POET did not disclose the value of those orders but said it i…

Insider Trades Friday: Executives Add to Stakes in Smaller Caps as Institutional Sellers Trim Big Winners

Insider Trades Friday: Executives Add to Stakes in Smaller Caps as Institutional Sellers Trim Big Winners

A selection of notable insider transactions disclosed on Friday shows company officers and directors making sizable purchases in Sonoco Products, NB Bancorp, Simply Good Foods and OneMedNet, while Magnetar-affiliated funds and Arista's CEO divested large holdings in CoreWeave and Arista Networks. The disclosed trades include multi-thousand and mult…

Commerzbank Climbs After BofA Upgrade as UniCredit Takeover Looms

Commerzbank Climbs After BofA Upgrade as UniCredit Takeover Looms

Commerzbank shares gained after BofA Global Research upgraded the stock to buy and raised its price target, while a looming public takeover offer from UniCredit and an upcoming strategy update keep the bank in a period of heightened scrutiny. BofA highlighted valuation upside and set forward-looking profitability forecasts for the lender under both…

Saudi Stocks End Higher as Petrochemicals, Cement, and Retail Lead Gains

Saudi Stocks End Higher as Petrochemicals, Cement, and Retail Lead Gains

Saudi Arabia's stock market closed higher on Monday, with the Tadawul All Share up 0.42%. Gains were concentrated in the Cement, Energy & Utilities and Retail sectors. Notable performers included Saudi Kayan Petrochemical, Rabigh Refining & Petrochemical and Yanbu National Petrochemical, while several paper and services names recorded declines. Oil…

FDA Grants Breakthrough Therapy Designation to TERN-701 for Certain Chronic Myeloid Leukemia Patients

FDA Grants Breakthrough Therapy Designation to TERN-701 for Certain Chronic Myeloid Leukemia Patients

Terns Pharmaceuticals said on Monday that the U.S. Food and Drug Administration has awarded Breakthrough Therapy Designation to its oral allosteric BCR::ABL1 inhibitor, TERN-701, for adults with chronic phase chronic myeloid leukemia without the T315I mutation who have previously received two or more tyrosine kinase inhibitors. The decision was bas…

HawkEye 360 Opens IPO Roadshow, Seeks Up to $416 Million

HawkEye 360 Opens IPO Roadshow, Seeks Up to $416 Million

HawkEye 360 initiated an initial public offering roadshow on April 27, proposing 16 million common shares priced between $24.00 and $26.00 each. With a 30-day overallotment option for an additional 2.4 million shares, the deal could generate about $416 million at the top of the range if that option is fully exercised. The company aims to list on th…

HawkEye 360 Begins IPO Roadshow, Seeks Up to $416 Million in Offering

HawkEye 360 Begins IPO Roadshow, Seeks Up to $416 Million in Offering

HawkEye 360 launched the roadshow for its initial public offering, proposing to sell 16 million shares priced between $24.00 and $26.00 each and naming an overallotment option that could lift proceeds to about $416 million. The company has filed a registration statement with the Securities and Exchange Commission that has not yet become effective, …

Compass Therapeutics Shares Plunge After Mixed COMPANION-002 Results

Compass Therapeutics Shares Plunge After Mixed COMPANION-002 Results

Compass Therapeutics stock dropped 80% after the company released data from its COMPANION-002 Phase 2/3 trial of tovecimig in biliary tract cancer. The combination of tovecimig and paclitaxel improved progression-free survival and response rate but did not achieve statistical significance for overall survival, with the analysis confounded by substa…

TSX Futures Slip as Geopolitics and a Heavy Earnings Calendar Loom

TSX Futures Slip as Geopolitics and a Heavy Earnings Calendar Loom

Futures tied to Canada’s principal equity gauge moved lower Monday as investors prepared for a week loaded with quarterly earnings, central bank guidance and persistent geopolitical tensions between the U.S. and Iran that have disrupted crude flows through the Strait of Hormuz. U.S. contracts were mixed, oil prices rose and gold remained subdued ah…